Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Molecular Cancer Therapeutics
|
June 4, 2017
The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target
Melanie A Blevins, Mingxia Huang, Rui Zhao
Expert Opinion on Therapeutic Targets
|
January 4, 2015
The SIX1-EYA transcriptional complex as a therapeutic target in cancer
Melanie A Blevins, Christina G Towers, Aaron N Patrick, et al.
Molecular Oncology
|
June 8, 2018
CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression
Melanie A Blevins, Caiguo Zhang, Lingdi Zhang, et al.
Chemmedchem
|
June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
Lukas Gardner, John Rossi, Brock Armstrong, et al.
Journal of Biomolecular Screening
|
December 6, 2014
Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression
Melanie A Blevins, Jennifer Kouznetsova, Aaron B Krueger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2018
Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model
Jingjing Luo, Li Bian, Melanie A Blevins, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Molecular Cancer Therapeutics
|
July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells
Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Cancer Research
|
April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis
Hengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Molecular Cancer Therapeutics
|
June 4, 2017
The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target
Melanie A Blevins, Mingxia Huang, Rui Zhao
Expert Opinion on Therapeutic Targets
|
January 4, 2015
The SIX1-EYA transcriptional complex as a therapeutic target in cancer
Melanie A Blevins, Christina G Towers, Aaron N Patrick, et al.
Molecular Oncology
|
June 8, 2018
CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression
Melanie A Blevins, Caiguo Zhang, Lingdi Zhang, et al.
Chemmedchem
|
June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
Lukas Gardner, John Rossi, Brock Armstrong, et al.
Journal of Biomolecular Screening
|
December 6, 2014
Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression
Melanie A Blevins, Jennifer Kouznetsova, Aaron B Krueger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2018
Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model
Jingjing Luo, Li Bian, Melanie A Blevins, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Molecular Cancer Therapeutics
|
July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells
Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Cancer Research
|
April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis
Hengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
Page
of 1